SCHEDULE: Gagnon Entities Report 5.0% Stake in OraSure Technologies

Neil Gagnon and affiliated entities, Gagnon Securities LLC and Gagnon Advisors, LLC, have reported a combined beneficial ownership of 5.0% in OraSure Technologies Inc. common stock.

Summary

• Neil Gagnon, along with Gagnon Securities LLC and Gagnon Advisors, LLC, collectively reported beneficial ownership of 3,590,538 shares of OraSure Technologies Inc. common stock.
• This represents 5.0% of the company's outstanding common stock, based on 71,733,530 shares as of October 31, 2025.
• Gagnon Securities LLC beneficially owns 1,765,491 shares, accounting for 2.5% of the class.
• Gagnon Advisors, LLC beneficially owns 1,207,440 shares, accounting for 1.7% of the class.
• Neil Gagnon directly holds sole voting and dispositive power over 381,594 shares and shared power over an additional 3,123,419 shares for voting and 3,208,944 shares for dispositive purposes through his roles at the affiliated entities.
• The filing explicitly states that the securities were not acquired for the purpose of changing or influencing control of OraSure Technologies Inc.

Sentiment

Score: 7

Explanation: The filing reports a significant passive stake by a reputable investment group, which is generally a positive signal of investor confidence. However, it contains no operational or financial performance data from the issuer, so the sentiment is moderately positive based solely on the ownership disclosure.

Positives

• A significant institutional investor and its affiliates have taken a 5.0% stake in OraSure Technologies Inc., potentially indicating confidence in the company's long-term prospects.
• The filing is a Schedule 13G, indicating a passive investment intent, which typically suggests the investor is not seeking to influence management or control.

Negatives

• No specific negative information is contained within this Schedule 13G filing, as it primarily reports ownership.

Risks

• No specific risks related to OraSure Technologies Inc. are detailed in this ownership filing, as it is a disclosure of ownership, not a risk assessment of the issuer.

Future Outlook

This filing does not contain forward-looking statements or guidance from the issuer or the reporting persons regarding the issuer's future performance. It is a disclosure of current ownership.

Management Comments

• The securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.
• Gagnon Securities LLC and Mr. Gagnon expressly disclaim beneficial ownership of all securities held in the Accounts.
• Gagnon Advisors and Mr. Gagnon expressly disclaim beneficial ownership of all securities held by GIA.

Industry Context

This filing indicates a significant passive investment by a known investment adviser and its principal in a biotechnology or diagnostic company (OraSure Technologies Inc.). Such an investment could be seen as a vote of confidence in the company's market position or future growth prospects within its sector, though the filing itself provides no specific industry analysis.

Comparison to Industry Standards

• This is a standard Schedule 13G filing, indicating passive ownership below the threshold for a Schedule 13D (which implies activist intent).
• A 5.0% stake is a notable position for an institutional investor, often placing them among the top shareholders, but it is not uncommon for investment firms to hold such positions in publicly traded companies.
• The disclaimers of beneficial ownership for client accounts are standard practice for investment advisers filing on behalf of their clients.

Stakeholder Impact

• Shareholders: The disclosure of a significant passive stake by an institutional investor might instill confidence among existing shareholders and potentially attract new investors.
• Management: Awareness of a 5.0% passive stake by a notable investment group could influence management's strategic considerations, though the filing explicitly states no intent to influence control.

Next Steps

• OraSure Technologies Inc. will continue its regular SEC reporting.
• Gagnon Securities LLC, Gagnon Advisors, LLC, and Neil Gagnon will file amendments to this Schedule 13G if their beneficial ownership changes significantly (e.g., crosses a 1% threshold up or down, or if their intent changes to active).

Key Dates

Recommendation

This Schedule 13G filing indicates a significant passive investment by Neil Gagnon and his affiliated entities in OraSure Technologies Inc. While a 5.0% stake from a reputable investment group can be seen as a positive signal of confidence, the filing itself provides no new operational or financial data about OraSure Technologies Inc. to warrant a 'buy' or 'sell' recommendation. Investors should 'hold' and await further fundamental analysis or company-specific news before making a definitive investment decision, using this ownership disclosure as one data point among many.

Keywords

OraSure Technologies, ORASURE, Gagnon Securities, Gagnon Advisors, Neil Gagnon, Schedule 13G, Beneficial Ownership, Institutional Investment, Common Stock, SEC Filing